The Safety, Dosimetry and Efficacy of 177Lu-FC516 in Patients With Prostate Cancer

NCT07542379 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

NOT_YET_RECRUITING

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: 177Lu-FC516

Sponsor

FindCure Biosciences (ZhongShan) Co., Ltd.

Collaborators

[object Object]